Management of Recurrent Severe Hypoglycemia in Diabetic Patients on Insulin

Introduction to Hypoglycemia Management

• The American Diabetes Association recommends a 10-20% dose reduction immediately for any episode of severe hypoglycemia without clear cause 1, 2
• For a patient with baseline glucose 145-180s, total daily insulin should not exceed 0.5 units/kg/day without clear indication, as stated by the American Diabetes Association 1, 2

Insulin Dose Adjustments

• Reduce Lantus from 45 units to 30-35 units (approximately 25% reduction) given the recurrent severe hypoglycemia episodes, as recommended by the American Diabetes Association 1, 2
• Reduce Novolog from 15 units to 10-12 units per meal (approximately 20-25% reduction) to prevent further hypoglycemic events, according to the American Diabetes Association 1, 2

Hypoglycemia Treatment and Prevention

• Immediately consume 15-20 grams of fast-acting carbohydrate (4 glucose tablets, 4 oz regular soda, 4 oz fruit juice) for conscious patients with glucose 50-70 mg/dL, as recommended by the American Diabetes Association 4, 5, 6
• Call 911 immediately for severe hypoglycemia (glucose <50 mg/dL or unconscious), and administer 1 mg glucagon intramuscularly if trained, as stated by the American Diabetes Association 3

Patient Education and Monitoring

• Inject insulin into subcutaneous tissue (abdomen, thigh, buttocks, upper arm), not into muscle, and rotate injection sites systematically, as recommended by the American Diabetes Association 7
• Maintain consistent carbohydrate intake at meals (45-60 grams per meal) and check glucose before driving—do not drive if <80 mg/dL, according to the American Diabetes Association 1, 2

Glycemic Targets and Long-Term Management

• Fasting glucose target: 100-130 mg/dL (not 80-130 mg/dL given recurrent severe hypoglycemia), as recommended by the American Diabetes Association 1, 2
• Postprandial glucose target: <180 mg/dL, and HbA1c target: 7.0-7.5% (less stringent target appropriate for patient with history of severe hypoglycemia), according to the American Diabetes Association 1, 2